// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Impact of Baseline Peri-Stent Plaque Volume on Positive Vessel Remodeling after Implantation of Paclitaxel Eluting Stents: A Pooled Volumetric Intravascular Ultrasound Analysis

Kenji Sakamoto - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Neoatherosclerosis And Impaired Vascular Healing Are Associated With Clinical Presentation Late After Coronary Stent Implantation. An Optical Coherence Tomography Study

Antonios Karanasos - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Everolimus-Eluting Stents in Diabetic Patients - A Prospective Non-Randomized Single Center Long Term Comparison

Pierre Sprimont - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Impact of Diabetes Mellitus on Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease

Giuseppe Ferrante - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Everolimus

Clinical Outcome Of Biolimus-Eluting Versus Sirolimus-Eluting Coronary Stent Implantation In Patients With And Without Diabetes Mellitus: A SORT OUT V Substudy

Michael Maeng - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Excel II

Long-Term Outcomes of Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents in Patients with Diabetes: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 4 and LEADERS Randomized Trials

Lamin King - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Rapacan

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

Giulio Stefanini - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Outcomes According to Sex Following Unprotected Left Main Stenting With Drug-Eluting Stents: The Milan Experience

Gill Buchanan - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Comparison of procedural and long-term outcomes between transradial and transfemoral approach for triple vessel coronary artery disease intervention

Kefei Dou - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

TR-4

Percutaneous Ultrasound-Guided Thrombin Injection as a Safe and Efficacious Primary Treatment of Iatrogenic Femoral Pseudoaneurysms for the Interventional Cardiologist

Daniel Chen - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Efficacy and Safety of Total Percutaneous Femoral Closure Following Stent Graft Implantation Using Preclose Technique

Won Ho Kim - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Large 22 to 24Fr femoral vein hemostasis with a subcutaneous stitch or a double Perclose closure is effective and safe

Asma Hussaini - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Protamine Sulfate

Incidence of Procedural Complications in Patients Undergoing Percutaneous Coronary Chronic Total Occlusion Interventions: A Systematic Review and Meta-Analysis

Vishal Patel - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation With Zotarolimus-Eluting Stent Implantation For The Treatment Of Total Coronary Occlusions

Koen Teeuwen - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Elderly Patients (75 years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry

Loes Hoebers - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Short and Long Term Clinical Outcomes of Chronic Total Occlusion Treatment with a Latest Generation Drug Eluting Stent

Alejandro Alcocer Chauvet - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Crofelemer

Coronary Chronic Total Occlusion Revascularization: Immediate Procedural Outcomes from a Multicenter US Registry

Dimitri Karmpaliotis - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

The use of a dedicated coronary bifurcation stent in patients presenting with myocardial infarction

Maik Grundeken - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Late Outcomes of Patients with Myocardial Infarction Undergoing Drug-Eluting Stent Implantation in Daily Clinical Practice

Ricardo Costa - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prevalence, Correlation and Clinical Outcome of Intra-procedural Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Coronary Syndrome

Yingjia Xu - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved